U.S. Trade Distributors Stock News

NYSE:DNOW
NYSE:DNOWTrade Distributors

DNOW (DNOW) Sets Earnings Date, Is The Stock Still 13% Undervalued?

DNOW Inc. (DNOW) has set August 6, 2026, for its second quarter earnings release and conference call, giving investors a fresh look at the distributor's performance and capital allocation priorities. See our latest analysis for DNOW. At a share price of $14.12, DNOW has seen a 10.31% 1 month share price return and a 5.69% year to date share price return, while the 1 year total shareholder return declined 4.21% and the 5 year total shareholder return is 79.42%. This suggests shorter term...
NasdaqGS:IBRX
NasdaqGS:IBRXBiotechs

ImmunityBio (IBRX) Could Be 45% Undervalued On UAE ANKTIVA Approval

What the UAE ANKTIVA approval means for ImmunityBio stock ImmunityBio (IBRX) is back on investor radar after the Emirates Drug Establishment in the UAE granted marketing authorization for ANKTIVA across two cancer indications, expanding the therapy’s global regulatory footprint. The decision covers ANKTIVA in combination with BCG for BCG unresponsive non muscle invasive bladder cancer and with immune checkpoint inhibitors for metastatic non small cell lung cancer. For shareholders, the...
NasdaqGS:EQIX
NasdaqGS:EQIXSpecialized REITs

Equinix (EQIX) Raises Fresh Debt As Investors Ask If The AI Data Center Story Is Priced In

Equinix (EQIX) has been active in the capital markets, completing several fixed income offerings that include senior callable fixed rate notes across 2029, 2033 and 2036 maturities, alongside additional fixed rate note announcements. See our latest analysis for Equinix. Equinix shares have eased in the short term, with the share price down 2.70% over one day and 5.99% over seven days. However, the year to date share price return of 33.39% and 1 year total shareholder return of 35.08% still...
NasdaqGS:KYIV
NasdaqGS:KYIVWireless Telecom

Does Kyivstar Group (NasdaqGS:KYIV) Trade At A Premium Or Fair Value?

Kyivstar Group stock has delivered a 30.1% return over the past year, yet its current checks point to pricing that looks broadly in line with fundamentals rather than clearly cheap or clearly expensive. The 30.1% one year gain puts recent shareholders comfortably ahead, which raises the question of how much of Kyivstar Group's progress is already reflected in the share price. Growth in digital services and new partnerships around areas such as AI and mobility can support revenue...
NYSE:SSB
NYSE:SSBBanks

SouthState Bank (SSB) Stock Looks Cheap With Strong Returns And Modest Earnings Price

SouthState Bank has delivered a 64.0% total return over the past 5 years, yet its current share price of US$105.09 still screens as cheap against an intrinsic value estimate from the Excess Returns model and traditional market multiples. With several valuation checks pointing in the same direction, investors are weighing whether the current discount reflects mispricing or a fair assessment of the bank’s risks. Over the last 5 years SouthState Bank has returned 64.0%, which already represents...
NasdaqGS:ABCL
NasdaqGS:ABCLLife Sciences

AbCellera Biologics (ABCL) Signs Vertex Deal, Is The Stock Still Cheap?

AbCellera Biologics (NasdaqGS:ABCL) shares are in focus after the company announced a new collaboration with Vertex Pharmaceuticals to discover, develop, manufacture, and commercialize multispecific T cell engagers for autoimmune diseases. See our latest analysis for AbCellera Biologics. The Vertex deal lands at a time when AbCellera Biologics has shown mixed momentum, with a 7.53% 7 day share price return, a 28.89% 90 day share price return, and a 34.67% 1 year total shareholder return,...
NasdaqGS:ADI
NasdaqGS:ADISemiconductor

Should Upbeat Earnings Revisions Around AI and Electrification Require Action From Analog Devices (ADI) Investors?

Recently, Analog Devices attracted increased investor attention after analysts raised their earnings estimates and Zacks assigned the company a Rank #2 (Buy), signaling stronger profit expectations across its core markets. This shift in forecasts highlights how changing views on Analog Devices’ earnings power in automation, AI, and electrification can reshape its broader investment appeal. Now we’ll examine how these upward earnings estimate revisions may influence Analog Devices’ existing...
NYSE:FLUT
NYSE:FLUTHospitality

Flutter Entertainment (FLUT) Stock Still Looks Cheap On Its 65% Slump

Flutter Entertainment stock is down 65.1% over the past year. Yet the broader valuation checks still lean toward the shares looking cheap rather than fully priced. With sentiment starting to shift after recent research pointing to easing concerns around prediction markets, the gap between weak past returns and a supportive valuation read is back in focus for investors. Over the last 12 months, Flutter Entertainment has declined 65.1%, which means the market has already priced in a...
NasdaqGS:ULCC
NasdaqGS:ULCCAirlines

Why Frontier Group (ULCC) Is Up 16.2% After Revenue Jump But Deeper Net Loss In Q2

In late July 2026, Frontier Group Holdings, Inc. reported second-quarter results showing revenue rising to US$1,279 million from US$929 million a year earlier, while net loss widened to US$90 million and loss per share increased to US$0.39. Over the first half of 2026, revenue climbed to US$2,271 million from US$1,841 million, but net loss more than tripled to US$362 million, highlighting pressure on profitability despite higher sales. We’ll now examine how Frontier’s revenue growth...
NYSE:TDOC
NYSE:TDOCHealthcare Services

Teladoc Health (TDOC) Is Down 23.5% After Weak Q2 And Lower 2026 Guidance Has The Bull Case Changed?

In late July 2026, Teladoc Health reported second‑quarter results showing sales declining to US$606.93 million and a wider net loss of US$38.91 million, alongside lower basic loss per share from continuing operations of US$0.21. Management also issued guidance calling for continued losses in the third quarter and full year 2026, highlighting ongoing pressure from the BetterHelp mental health unit as more users move toward insurance-covered care. We’ll now examine how Teladoc’s weaker...
NYSE:ELAN
NYSE:ELANPharmaceuticals

Elanco (ELAN) Is Up 5.9% After Credelio Quattro Outperforms Rivals in Tick Protection Study

In July 2026, Elanco Animal Health reported new study results showing its Credelio Quattro chewable tablets kill black-legged and lone star ticks faster and more consistently through Day 28 than competing products Simparica Trio and NexGard Plus, while also carrying an FDA-approved claim for Lyme disease prevention in dogs. An important angle for investors is that Credelio Quattro’s rapid tick kill and Lyme prevention claim differentiate it within a crowded pet parasiticide market,...
NYSE:ENS
NYSE:ENSElectrical

Should EnerSys’ (ENS) Defense-Focused Greenville Lithium Shift Prompt a Rethink by Investors?

In July 2026, EnerSys updated its plans for a Greenville, South Carolina lithium cell plant, narrowing its focus to U.S.-based production for aerospace, defense, and specialized industrial customers, backed by an approximately US$150 million revised U.S. Department of Energy grant and about US$200 million in state and local incentives toward an estimated US$500 million investment. The shift away from its Verkor technology relationship toward long-standing aerospace and defense partners...
NYSE:PG
NYSE:PGHousehold Products

Procter & Gamble (PG) Faces A Leadership Reset, Is The Stock Cheap Enough?

Procter & Gamble (PG) has entered a transitional phase that is drawing fresh attention from investors. Softer fiscal 2027 guidance, leadership changes, and recent margin pressure are all converging to reshape the conversation around the stock. See our latest analysis for Procter & Gamble. At a share price of US$144.49, Procter & Gamble has had a modest 1.9% year to date share price return, while the 1 year total shareholder return is down 1.27%. This suggests that momentum has cooled as...
NasdaqGS:NBIS
NasdaqGS:NBISSoftware

Does Nebius’ US$1 Billion AI Cloud Deal and New Debt Shift The Bull Case For NBIS?

Nebius Group recently secured a multiyear AI cloud contract worth more than US$1 billion, activated new Nvidia-powered capacity in Finland, and arranged a US$775 million senior secured debt facility to fund its global AI infrastructure expansion. These deals, backed by long-dated commitments from large technology customers and collateralized GPU assets, highlight how Nebius is tying its growth plans directly to contracted AI compute demand rather than relying solely on equity financing. With...
NYSE:NE
NYSE:NEEnergy Services

Will Weaker Q2 Results and Lower 2026 Outlook Change Noble's (NE) Capital Returns Narrative?

Noble Corporation plc recently reported second-quarter 2026 results showing revenue of US$719.69 million and a net loss of US$36.68 million, and subsequently lowered its full-year 2026 revenue guidance to US$2.80–US$2.90 billion. Despite weaker earnings and reduced guidance, the company maintained its US$0.50 per share third-quarter dividend and has completed a US$29.82 million share repurchase program, underscoring an ongoing commitment to capital returns. We’ll now examine how Noble’s...
NasdaqGS:SYBT
NasdaqGS:SYBTBanks

Stock Yards Bancorp (SYBT) Earnings Improved, Is The Stock Still Cheap?

Stock Yards Bancorp earnings put recent moves in context Stock Yards Bancorp (SYBT) has drawn fresh attention after reporting second quarter and first half 2026 results, with both net interest income and net income higher than the same periods a year earlier. For the second quarter, net interest income was US$87.83 million compared with US$73.47 million a year ago, while net income reached US$40.06 million versus US$34.02 million. Basic earnings per share from continuing operations were...
NasdaqCM:LQDA
NasdaqCM:LQDAPharmaceuticals

Is Liquidia (LQDA) Stock Too Rich After A 35x Run?

Liquidia has delivered an extremely strong run over the past few years, yet the stock now screens as expensive on the broader valuation checks. That combination puts the recent share price strength up against a weak overall value score and an overvalued read on market multiples. Liquidia has returned roughly 35x over the past 5 years, which sets a high bar for any further upside to be justified by fundamentals. Expectations for the company to convert its pipeline and business model into...
NYSE:GPI
NYSE:GPISpecialty Retail

Group 1 Automotive (GPI) Stock Looks Undervalued Even As Risks Persist

Group 1 Automotive stock has pulled back sharply over the past year, yet the broader valuation checks still point to shares that look cheap relative to the company’s fundamentals. With the price around US$286.77 and longer term holders still sitting on strong gains, investors are weighing whether the recent weakness has opened up value or is signalling a shift in the story. Group 1 Automotive has delivered a 77.8% total return over the past 5 years, which suggests the longer term share price...
NYSE:BKT
NYSE:BKTCapital Markets

Prologis Stock Faces A Tougher Test As Treasury Yields Reshape Investor Flows

Soaring Treasury yields and richer returns on inflation protected bonds are pulling investor attention away from parts of the stock market and toward government debt. That shift in retirement flows and institutional asset allocation can pressure some stocks that rely heavily on equity demand, while others tied more directly to long term Treasuries may see stronger interest. This article walks through three stocks that are closely linked to this story, with one that could be positioned on the...
NasdaqGS:PLXS
NasdaqGS:PLXSElectronic

Plexus (PLXS) Beat Expectations, Is The Stock Still Cheap?

Plexus (PLXS) has drawn investor attention after reporting fiscal third quarter results that exceeded revenue and adjusted earnings expectations, alongside 31 new manufacturing program wins and fresh guidance pointing to continued revenue and margin growth. See our latest analysis for Plexus. Plexus shares have pulled back recently, with a 30 day share price return of 8.64% and a 90 day return of 5.01%. However, the year to date share price return of 65.11% and 1 year total shareholder return...
NYSE:ETR
NYSE:ETRElectric Utilities

Is Entergy (ETR) Fairly Valued As Its Fresh Dividend Puts Income In Focus?

Entergy (ETR) has been in focus after its board declared a quarterly dividend of $0.64 per share, payable on September 1, 2026, to shareholders of record as of August 13, 2026. See our latest analysis for Entergy. Entergy's recent dividend decision comes as the stock has eased in the short term, with the share price down over the past week and quarter, while longer term total shareholder returns over one, three and five years remain strong and indicate momentum built over time. If this...